Join us for a candid conversation with Christi Shaw, Senior Vice President and President, Lilly Bio-Medicines. For Christi Shaw, “More Moments for More Memories” isn’t just a mantra – it’s a personal and professional mission. She leads through the lens of innovation, integrity and inclusion and brings an unwavering commitment to addressing the evolving needs of patients, in collaboration with healthcare professionals, advocacy groups, payers and policy makers. Shaw re-joined Eli Lilly and Company in April 2017 as Senior Vice President and President of Lilly Bio-Medicines. Leading Lilly’s broadest therapeutic portfolio, Shaw oversees late-stage clinical development and commercialization for the company’s leading positions in Immunology, Pain, Migraine and Alzheimer’s disease, some of Lilly’s most significant opportunities to make life better for patients. She also leads commercial responsibilities in the world’s largest markets for the above mentioned Lilly medicines' therapeutic areas as well as in neuroscience and osteoporosis.